1. Home
  2. SEED vs INKT Comparison

SEED vs INKT Comparison

Compare SEED & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEED
  • INKT
  • Stock Information
  • Founded
  • SEED 1997
  • INKT 2017
  • Country
  • SEED China
  • INKT United States
  • Employees
  • SEED N/A
  • INKT N/A
  • Industry
  • SEED Farming/Seeds/Milling
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • SEED Consumer Staples
  • INKT Health Care
  • Exchange
  • SEED Nasdaq
  • INKT Nasdaq
  • Market Cap
  • SEED 8.6M
  • INKT 69.2M
  • IPO Year
  • SEED N/A
  • INKT 2021
  • Fundamental
  • Price
  • SEED $1.94
  • INKT $14.87
  • Analyst Decision
  • SEED
  • INKT Buy
  • Analyst Count
  • SEED 0
  • INKT 3
  • Target Price
  • SEED N/A
  • INKT $37.50
  • AVG Volume (30 Days)
  • SEED 3.3M
  • INKT 32.0K
  • Earning Date
  • SEED 06-26-2025
  • INKT 11-13-2025
  • Dividend Yield
  • SEED N/A
  • INKT N/A
  • EPS Growth
  • SEED N/A
  • INKT N/A
  • EPS
  • SEED N/A
  • INKT N/A
  • Revenue
  • SEED $12,910,081.00
  • INKT N/A
  • Revenue This Year
  • SEED N/A
  • INKT N/A
  • Revenue Next Year
  • SEED N/A
  • INKT N/A
  • P/E Ratio
  • SEED N/A
  • INKT N/A
  • Revenue Growth
  • SEED N/A
  • INKT N/A
  • 52 Week Low
  • SEED $0.74
  • INKT $4.56
  • 52 Week High
  • SEED $3.11
  • INKT $76.00
  • Technical
  • Relative Strength Index (RSI)
  • SEED 71.61
  • INKT 51.85
  • Support Level
  • SEED $1.85
  • INKT $13.88
  • Resistance Level
  • SEED $2.22
  • INKT $15.00
  • Average True Range (ATR)
  • SEED 0.25
  • INKT 0.81
  • MACD
  • SEED 0.06
  • INKT 0.03
  • Stochastic Oscillator
  • SEED 57.26
  • INKT 48.11

About SEED Origin Agritech Limited

Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: